MarketInOut Stock Screener Log In | Sign Up
 

Icon Plc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 05/11/2026 10:32
Icon Plc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization9,681.85 mln
Float75.95 mln
Earnings Date07/29/2026

EPS

7.42
Strong

P / E

16.42
Moderately valued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.54
Likely reliable

1-Year Forecast

137
Modest upside

Relative Strength

92 / 100
Top performer

Business Description

Founded in 1989 and headquartered in Dublin, Ireland, ICON Public Limited Company helps pharmaceutical, biotechnology, medical device, and public health organizations bring new treatments to market. The company manages the full journey of clinical trials, from early compound testing through all phases of development and beyond, offering services that include laboratory work, data analysis, patient access, medical imaging, and regulatory support. ICON also provides consulting, contract staffing, and commercial strategy services to help clients design, run, and complete studies efficiently. The company operates across Europe, the United States, and internationally, and maintains a strategic partnership with Advarra Inc. to build a connected network of trial-ready research sites.

Key Fundamentals

EPS7.42
P/E16.42
ROE6.29
RPS101
ROIC6.81
ROA3.57
Interest Cover6.73
EBITDA, mln1,179
EV / EBITDA10.06
EV / EBIT15.01
Revenue, mln8,103
EV / Revenue1.46

Financial Strength

Altman Z-Score1.62
Piotroski F-Score 5 / 9
Beneish M-Score-2.54
Price to Intrinsic Value0.52
Price to Lynch Fair Value0.57
1-Year Target Price137
Shiller PE Ratio18.09
Short Ratio3.50
Short % of Float4.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.85% 87 / 100   
1 Month 14.11% 77 / 100   
2 Months -31.75% 11 / 100   
6 Months -23.83% 22 / 100   
1 Year -11.99% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us